Accelr8 Announces Extension by NYSE & Acceptance of the Company’s Plan to Regain Compliance for Continued Listing on the NY...
March 19 2009 - 8:55AM
Business Wire
Accelr8 Technology Corporation (NYSE Alternext US: AXK)
(the �Company�) announced today that on March 18, 2009 it received
a notice from the staff (the �Exchange Staff�) of NYSE Alternext US
LLC (the "NYSE Alternext," which is the successor to the American
Stock Exchange) indicating that the Exchange Staff granted a
listing extension on the basis of the plan submitted by the Company
to regain compliance with listing standards by July 6, 2010.
Specifically, the Company has shown how it plans to regain
compliance with Section 1003(a)(iii) of the Company Guide with
objectives to include stockholders� equity to equal or exceed
$6,000,000 and for continuing operations and net income to reverse
from losses sustained in its five most recent fiscal years.
About Accelr8
Accelr8 Technology Corporation (www.accelr8.com) is a developer
of innovative materials and instrumentation for advanced
applications in medical instrumentation, basic research, drug
discovery, and bio-detection. Accelr8 is developing rapid clinical
pathogen platforms, the BACcel�, based on its innovative surface
coatings, assay processing, and detection technologies. In
addition, Accelr8 licenses certain of its proprietary technology
for use in applications outside of Accelr8�s own products.
Certain statements in this news release may be �forward-looking
statements� within the meaning of Section 27A of the Securities Act
of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended. Statements regarding future prospects and
developments are based upon current expectations and involve
certain risks and uncertainties that could cause actual results and
developments to differ materially from the forward-looking
statement, including those detailed in the company's filings with
the Securities and Exchange Commission. Accelr8 does not undertake
an obligation to publicly update or revise any forward-looking
statements, whether as a result of new information or future
events.
Accelr8 (AMEX:AXK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Accelr8 (AMEX:AXK)
Historical Stock Chart
From Jul 2023 to Jul 2024
